Books by Subject

Anti-Infective Agents

  • Digital/Print
    [written by Abigail Wright, Matteo Zignol].
    Digital : WHO2008
    Print2008
  • Digital
    [edited by] Roger Finch ... [et al.].
    ClinicalKey2010
    1. Historical introduction -- 2. Modes of action -- 3. The problem of resistance -- 4. Pharmacodynamics of anti-infective agents: target delineation and susceptibility breakpoint selection -- 5. Antimicrobial agents and the kidneys -- 6. Drug interactions involving anti-infective agents -- 7. Antibiotics and the immune system -- 8. General principles of antimicrobial chemotherapy -- 9. Laboratory control of antimicrobial therapy -- 10. Principles of chemop rophylaxis -- 11. Antibiotic policies -- 12. Aminoglycosides and aminocyclitols -- 13. β-Lactam antibiotics : cephalosporins -- 14. β-Lactam antibiotics: penicillins -- 15. Other β-lactam antibiotics -- 16. Chloramphenicol and thiamphenicol -- 17. Diaminopyrimidines -- 18. Fosfomycin and fosmidomycin -- 19. Fusidanes -- 20. Glycopeptides -- 21. Lincosamides -- 22. Macrolides -- 23. Mupirocin -- 24. Nitroimidazoles -- 25. Oxazolidinones -- 26. Quinolones -- 27. Rifamycins -- 28. Streptogramins -- 29. Sulfonamides -- 30. Tetracyclines -- 31. Miscellaneous antibacterial agents -- 32. Antifungal agents -- 33. Antimycobacterial agents -- 34. Anthelmintics -- 35. Antiprotozoal agents -- 36. Antiretroviral agents -- 37. Other antiviral agents -- 38. Sepsis -- 39. Abdominal and other surgical infections -- 40. Infections associated with neutropenia and transplantation -- 41. Infections in intensive care patients -- 42. Infections associated with implanted medical devices -- 43. Antiretroviral therapy for HIV -- 44. Infections of the upper respiratory tract -- 45. Infections of the lower respiratory tract -- 46. Endocarditis -- 47. Infections of the gastrointestinal tract -- 48. Hepatitis -- 49. Skin and soft-tissue infections -- 50. Bacterial infections of the central nervous system -- 51. Viral infections of the central nervous system -- 52. Bone and joint infections -- 53. Infections of the eye -- 54. Urinary tract infections -- 55. Infections in pregnancy -- 56. Sexually transmitted diseases -- 57. Leprosy -- 58. Tuberculosis and other mycobacterial infections -- 59. Superficial and mucocutaneous mycoses -- 60. Systemic fungal infections -- 61. Zoonoses -- 62. Malaria -- 63. Other protozoal infections -- 64. Helminthic infections.
  • Digital
    Thomas J. Dougherty, Michael J. Pucci, editors.
    Springer2012
  • Digital
    Ian M. Gould, Jos W.M. van der Meer, editors.
    Springer2011
  • Digital
    edited by Anthony R.M. Coates.
    Springer2012
    Introduction to antibiotic resistance/ Richard Bax, David Griffin -- The origins of antibiotic resistance/ Gerard D. Wright -- Surveillance programmes and antibiotic resistance: worldwide and regional monitoring of antibiotic resistance trends/ Stephen Hawser -- Current and future challenges in the development of antimicrobial agents/ Robert P. Rennie -- The role of the outer membrane of gram-negative bacteria in antibiotic resistance: Ajax' shield or Achilles' heel?/ Malcolm G.P. Page -- Prevention of drug resistance by combined drug treatment of tuberculosis/ Denis A. Mitchison -- Nonmultiplying bacteria are profoundly tolerant to antibiotics / Yanmin Hu, Anthony Coates -- Persister cells: molecular mechanisms related to antibiotic tolerance / Kim Lewis -- Antimicrobial textiles / J. Vaun McArthur, R.C. Tuckfield, C. Baker-Austin -- Efflux: how bacteria use pumps to control their microenvironment / E. David G. McIntosh -- Antibiotics in phase II and III clinical trials / Anthony R.M. Coates, Gerry Halls.
  • Digital
    This brief provides an overview of antibiotic resistance, including a summary of its current impact, the factors that contribute to its spread, and the policy recommendations put in place by federal and global public health agencies. It also reviews the debate around the regulation of antibiotic use in agriculture and examines new developments in policy and research associated with multidrug-resistant bacterial diseases and their underlying causes.
  • Digital
    [edited by] Kateryna Kon, MD, PhD, Department of Microbiology, Virology, and Immunology, Kharkiv National Medical University, Kharkiv, Ukraine and Mahendra Rai, PhD, Biotechnology Department, SGB Amravati University, Maharashtra, India.
    ClinicalKey2016
    Antimicrobial Stewardship: Hospital Strategies to Curb Antibiotic Resistance / L. Hsieh and A. Amin -- Mechanisms of Antibacterial Resistance: Shedding Some Light on These Obscure Processes? / K. de Sousa Oliveira, L.A. de Lima, N.B. Cobacho, S.C. Dias and O.L. Franco -- Signaling Pathways Sustaining Antibiotic Resistance: Lessons From Methicillin-Resistant Staphylococcus auareus / P.F. Seke Etet, A.H. Nwabo Kamdje, L. Vecchio, M. Farahna, and M.F. Mahomoodally -- Trends in Antimicrobial Resistance Among Enteric Pathogens: a Global Concern / M. Ballal -- Carbapenem-Resistant, Gram-Negative Bacilli: The State of the Art / D.H.Halat, D.K. Sarkis and C.A. Moubareck -- Antibiotic Resistance: Can Nanoparticles Tackle the Problem? / M. Rai, K. Kon, A. Gade, A. Ingle, D. Nagaonkar, P. Paralikar and S.S. da Silva -- Nanoarchitectonics Used in Antiinfective Therapy / V. Grumezescu, A.M. Holban, I. Barbu, R.C. Popescu, A.E. Oprea, V. Lazar, A.M. Grumezescu and M.C.Chifiriuc -- Nanobiocomposites of Metals as Antimicrobial Agents / I.A. Shurygina, M.G. Shurygin and B.G. Sukhov -- Can Nitric Oxide Overcome Bacterial Resistance to Antibiotics? / A.B. Seabra, M.T. Pelegrino and P.S. Haddad -- Controlling Bacterial Antibiotic Resistance Using Plant-Derived Antimicrobials / A. Upadhyay, D.P. Karumathil, I. Upadhyaya, V. Bhattaram and K. Venkitanarayanan -- Essential Oils: A Natural Alternative to Combat Antibiotics Resistance / M.L. Chávez-González, R. Rodríguez-Herrera and C.N. Aguilar -- Sensitivity of ESBL-Producing Gram-Negative Bacteria to Essential Oils, Plant Extracts, and Their Isolated Compounds / Gy. Horváth, T. Bencsik, K. Ács and B. Kocsis -- Antimicrobial and Antibiotic Potentiating Activity of Essential Oils From Tropical Medicinal Herbs and Spices / Z. Aumeeruddy-Elalfi, A. Gurib-Fakim and M.F. Mahomoodally -- Antimicrobial Natural Products Against Bacterial Biofilms / V.G. Beoletto, M. de las Mercedes Oliva, J.M. Marioli, M.E. Carezzano and M.S. Demo -- The Potential Use of Bacteriophage Therapy as a Treatment Option in a Post-antibiotic Era / R.R. Bragg, C.E. Boucher, W.A. van der Westhuizen, J.-Y. Lee, E. Coetsee, C. Theron and L. Meyburgh -- Bacteriocins and Its Use for Multidrug-Resistant Bacteria Control / G.M. Preciado, M.M. Michel, S.L. Villarreal-Morales, A.C. Flores-Gallegos, J. Aguirre-Joya, J. Morlett-Chávez, C.N. Aguilar and R. Rodríguez-Herrera -- Marine Natural Products in Fighting Microbial Infections / G.D. Mogoşanu, A.M. Grumezescu, L.E. Bejenaru and C. Bejenaru -- Algae as a Novel Source of Antimicrobial Compounds: Current and Future Perspectives / A. Parsaeimehr and G.A. Lutzu.
  • Digital
    David M. Shlaes.
    Springer2010
  • Digital
    Daniel Amsterdam, Phd, ABMM, FAAAS, FIDSA, Professor, Department of Microbiology & Immunology, Medicine, and Pathology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Chief of Service, Department of Laboratory Medicine, Erie County MEdical Center, Buffalo, New York.
    Ovid2015
    The breakpoint / Matthew A. Wikler, Franklin R. Cockerill III, and Paul G. Ambrose -- Antimicrobial susceptibility on solid media / John D. Turnidge and Jan M. Bell -- Susceptibility testing of antimicrobials in liquid media / Daniel Amsterdam -- Antimicrobial susceptibility testing of anaerobic bacteria / Anilrudh A. Venugopal and David W. Hecht -- Antimycobacterial agents : in vitro susceptibility testing and mechanisms of action and resistance / Clark B. Inderlied and Edward Desmond -- Antifungal drugs : mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biologic fluids / George R. Thompson III and Thomas F. Patterson -- Antimicrobial susceptibility testing for some atypical microorganisms (Chlamydia, Mycoplasma, Rickettsia, Ehrlichia, Coxiella, and Spirochetes) / Jean-Marc Rolain -- Applications, significance of, and methods for the measurement of antimicrobial concentrations in human body fluids / Shelly Latte, Emilia Mia Sordillo, and Stephen C. Edberg -- Molecular methods for the detection of antibacterial resistance genes : rationale and application / Kristin Hegstad, Törjan Samuelsen, Joachim Hegstad, and Arnfinn Sundsfjord -- Molecular mechanisms of action for antimicrobial agents : general principles and mechanisms for selected classes of antibiotics / Charles William Stratton -- Antiviral agents for HIV, hepatitis, cytomegalovirus, and influenza : susceptibility testing methods, modes of action, and resistance / Daniel Amsterdam -- Disinfectants and antiseptics : modes of action, mechanisms of resistance, and testing regimens / Daniel Amsterdam and Barbara E. Ostrov -- Evaluation of antimicrobials in experimental animal infections / D.A. Andes, Alexander J. Lepak, Niels Frimodt-Möller -- Extravascular antimicrobial distribution and the respective blood and urine concentrations in humans / David M. Bamberger, John W. Foxworth, Michael Alan Kallenberger, Brian S. Pepito, and Dale N. Gerding -- Appendix : antiinfective resistance resource guide / Daniel Amsterdam.
  • Digital
    by David Schlossberg, Rafik Samuel.
    Wiley2017
    A comprehensive compendium of all commonly used antibiotics, including indications, side effects, dosage information, and drug/food interactions Antibiotics Manual: A Guide to Commonly Used Antimicrobials, Second Edition is a unique, user-friendly guide made for all who prescribe antibiotics. It's the only book available that takes a 100% drug-listed approach to 200 of the most common antibiotics prescribed to patients each day. Presented in full color, it's also a convenient reference for every clinician to consult once the decision to use a particular antibiotic has been reached. This edition of Antibiotics Manual includes newer antibiotics that have been released since the publication of the First Edition and updates prescribing information for the older antibiotics. This all-new Second Edition: -Has a color-coded interior design which provides quick and easy point of care access for the user -Includes 200 of the most commonly prescribed antibiotics, listed by both brand and generic names -Features important recently-released antibiotics such as ceftaroline, tedizolid, and bedaquiline Antibiotics Manual: A Guide to Commonly Used Antimicrobials, Second Edition is a welcome book for physicians in all specialties of medicine who prescribe antibiotics. It is also a handy tool for pharmacists, nurses, nurse practitioners, and physician assistants who want more information on the drugs they administer.
  • Digital
    Jason C. Gallagher, Conan MacDougall ; senior acquisitions editor, Katey Birtcher ; cover design, Michael O'Donnell.
    ProQuest Ebook Central2014Limited to 2 simultaneous users
    Part 1. Considerations with antibiotic therapy -- Part 2. Antibacterial drugs -- Part 3. Antimycobacterial drugs -- Part 4. Antifungal drugs -- Part 5. Antiviral drugs -- Part 6. Antiparasitic Drugs -- Appendix 1. Selected normal human flora -- Appendix 2. Spectrum of activity -- Appendix 3. Empiric regimens for common infections -- Index.
  • Digital
    DatabaseLimited to 6 simultaneous users
    Includes information on antimicrobial therapy and alternative therapy when the drug of choice cannot be given. The resource delivers information via review articles, capsule summaries, mini-reviews, and a guided PubMed search to pick up post-publication research.
  • Digital
    Davey, Peter; Finch, R. G.; Irving, Wiliam L.; Wilcox, Mark.
    Ovid2012
    Pt. 1. General properties of antimicrobial agents -- Pt. 2. Resistance to antimicrobial agents -- Pt. 3. General principles of usage of antimicrobial agents -- Pt. 4. Therapeutic use of antimicrobial agents.
  • Digital
    Tomás G. Villa, Patricia Veiga-Crespo, editors.
    Springer2014
    Since penicillin and salvarsan were discovered, a number of new drugs to combat infectious diseases have been developed, but at the same time, the number of multi-resistant microorganism strains is increasing. Thus, the design of new and effective antibacterial, antiviral and antifungal agents will be a major challenge in the next years. This book reviews the current state-of-the-art in antimicrobial research and discusses new strategies for the design and discovery of novel therapies. Topics covered include the use of genetic engineering, genome mining, manipulation of gene clusters, X-ray and neutron scattering as well as the antimicrobial effects of essential oils, antimicrobial agents of plant origin, beta-lactam antibiotics, antimicrobial peptides, and cell-wall-affecting antifungal antibiotics.
  • Print
    David Greenwood.
    "Antimicrobial drugs developed in the twentieth century revolutionized the ability of doctors to manage life-threatening infectious diseases. Although a few useful drugs, notably quinine for malaria, were already known, it was Paul Ehrlich's quest for derivatives of dyes and arsenical chemicals, culminating in the antisyphilitic compound Salvarsan in 1910, that kick-started modern antimicrobial chemotherapy. In the 1930s a major breakthrough came with the first sulphonamides. Soon afterwards, Howard Florey and his team at Oxford turned Alexander Fleming's fortuitous discovery of penicillin into the first 'miracle drug', starting a frantic and outstandingly successful hunt for naturally occurring antibiotics and synthetic chemicals with antimicrobial properties. The rich harvest that ensued transformed the prospects for the cure of infections of all kinds, whether caused by bacteria, viruses, fungi, protozoa, or helminthic worms. Antimicrobial drugs have surely relieved more human and animal suffering than any other class of drugs in the history of medical endeavour." "The story of this extraordinary medical triumph encompasses tales of individual brilliance, remarkable team efforts, perseverance in the face of much frustration, international rivalry, and the rise of the global pharmaceutical industry. Though scientists and commerce produced the miracle and reaped the rewards, Lady Luck was never far from the scene, and her frequent interventions add extra spice to this truly fascinating story."--Book jacket.
  • Digital
    David A. Phoenix, Sarah R. Dennison, and Frederick Harris.
    Wiley2013
    Antimicrobial peptides: their history, evolution, and functional promiscuity -- Cationic antimicrobial peptides -- Anionic antimicrobial peptides -- Graphical techniques to visualize the amphiphilic structures of antimicrobial peptides -- Models for the membrane interactions of antimicrobial peptides -- Selectivity and toxicity of oncolytic antimicrobial peptides.
  • Digital/Print
    World Health Organization.
    Digital : WHO2014
    Print2014
    This report examines, for the first time, the current status of surveillance and information on antimicrobial resistance (AMR) at country level worldwide, with particularly attention to antibacterial resistance.
  • Digital
    editors, Chin-Yi Chen, Xianghe Yan, Charlene R. Jackson.
    ScienceDirect2015
    1. Introduction to antimicrobial-resistant foodborne pathogens / Patrick Butaye, Maria Angeles Argudín and John Threlfall -- 2. Antimicrobial resistance of Shiga toxin-producing Escherichia coli / Jinru Chen -- 3. Antibiotic resistance in pathogenic Salmonella / Steven C. Ricke and Juliany Rivera Calo -- 4. Antimicrobial resistance and Campylobacter jejuni and C. coli / Mirko Rossi, Satu Olkkola, Mati Roasto, Rauni Kivistö and Marja-Liisa-Hänninen -- 5. Antimicrobial resistance in Yersinia enterocolitica / Anna Fabrega, Clara Ballesté-Delpierre and Jordi Vila -- 6. Antimicrobial resistance in Vibrio species / Craig Baker-Austin -- 7. Antimicrobial resistance in Shigella species / Keith A. Lampel -- 8. Antimicrobial resistance in Listeria spp. / Nathan A. Jarvis, Philip G. Crandall, Corliss A. O'Bryan and Steven C. Ricke -- 9. Antibiotic resistance in Enterococci : a food safety perspective / Anuradha Ghosh and Ludek Zurek -- 10. Clostridium difficile: a food safety concern? / Jane W. Marsh and Lee H. Harrison -- 11. Methods for the detection of antimicrobial resistance and the characterization of Staphylococcus aureus isolates from food-producing animals and food of animal origin / Kristina Kadlec, Sarah Wendlandt, Andrea T. Fessler and Stefan Schwarz -- 12. Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae / Agnese Lupo, Krisztina M. Papp-Wallace, Robert A. Bonomo and Andrea Endimiani -- 13. Monitoring and surveillance : the national antimicrobial resistance monitoring system / Emily Crarey, Claudine Kabera and Heather Tate -- 14. Risk assessment of antimicrobial resistance / H. Gregg Claycamp -- 15. Food microbial safety and animal antibiotics / Louis Anthony (Tony) Cox -- 16. Antibiotic-resistant bacteria and resistance genes in the water-food nexus of the agricultural environment / Pei-Ying Hong -- 17. Development and application of novel antimicrobials in food and food processing / Yangjin Jung and Karl R. Matthews -- 18. Database resources dedicated to antimicrobial peptides / Guangshun Wang -- 19. Metabolic network analysis-based identification of antimicrobial drug target in pathogenic bacteria / Vinayak Kapatral -- 20. Application of metagenomic technologies for antimicrobial resistance and food safety research and beyond / Chin-Yi Chen, Xianghe Yan, Siyun Wang and Charlene R. Jackson.
  • Digital
    [edited] by Patricia L. Keen, Raphaël Fugère.
    Wiley2018
    Antimicrobial resistance genes and wastewater treatment / Mehrnoush Mohammadali and Julian Davies -- When pathogens and environmental organisms meet : consequences for antibiotic resistance / Jose Luis Martinez and Fernando Baquero -- One health : the role wastewater treatment plants play as reservoirs, amplifiers, and transmitters of antibiotic resistance genes and antibiotic resistant bacteria / Marilyn C. Roberts -- Assessing the impact of wastewater treatment plants on environmental levels of antibiotic resistance / Jessica Williams-Nguyen, Irene Bueno, and Randall S. Singer -- Navigating through the challenges associated with the analysis of antimicrobials and their transformation products in wastewater / Randolph R. Singh, Rachel A Mullen and Diana S. Aga -- Metagenomic approaches for antibiotic resistance gene detection in wastewater treatment plants / Ying Yang and Tong Zhang -- Antimicrobials and antimicrobial resistant bacteria in Australia / Andrew J. Watkinson and Simon D. Costanzo -- The mobile resistome in wastewater treatment facilities and downstream environments / Roberto B.M. Marano and Eddie Cytryn -- Bacterial diversity and antibiotic resistance genes in wastewater treatment plant influents and effluents / Veiko Voolaid, Erica Donner, Sotirios Vasileiadis, and Thomas U. Berendonk -- The effect of advanced treatment technologies on the removal of antibiotic resistance -- Popi karaolia, Stella Michael, and Despo Fatta-Kassinos -- Antimicrobial resistance spread mediated by wastewater irrigation: the Mezquital Valley case study / Melanie Broszat and Elisabeth Grohmann -- Antimicrobial resistance related to agricultural wastewater and biosolids / Lisa M. Durso and Amy Millmier Schmidt -- Environmental antibiotic resistance associated with land application of biosolids / Jean E. Mclain, Channah M. Rock, and Charles P. Gerba -- High throughput method for analyzing antibiotic resistance genes in wastewater treatment plants / Johanna Muurinen, Antti Karkman, and Marko Virta -- Antibiotic resistance and wastewater treatment process / Thi Thuy Do, Sinéad Murphy, and Fiona Walsh -- Antibiotic pollution and occurrence of bacterial antibiotic resistance genes in Latin American developing countries : case study of the Katari watershed in the Bolivian highlands / Denisse Archundia, Celine Duwig, Jean M.F. Martins, Frederic Lehembre, Marie-Christine Morel, and Gabriela Flores -- Antimicrobial resistance in hospital wastewaters / Judith Isaac-Renton and Patricia L. Keen -- Curbing the resistance movement : examining public perception of the spread of antibiotic resistant organisms / Agnes V. Macdonald and Patricia L. keen -- Public health consequences of antimicrobial resistance in the wastewater treatment process / Patricia L. Keen, Raphaël Fugère, and David M. Patrick.
  • Digital
    edited by Matthew Laundy, Mark Gilchrist, Laura Whitney.
    Oxford Medicine Online2016
    Section 1. Setting the scene and starting up -- Section 2. Components of an antimicrobial stewardship programme -- Section 3. Special areas in antimicrobial stewardship.
  • Digital
    edited by Céline Pulcini, Onder Ergonul, Füsun Can, Bojana Beović.
    ScienceDirect2017
    Section 1: The global picture of antimicrobial use and resistance -- Section 2: AMS Strategies -- Section 3: AMS in specific clinical settings -- Section 4: AMS experience around the world -- Section 5: Research and perspectives.
  • Digital
    Flavia Marinelli, Olga Genilloud, editors.
    Springer2014
    Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the "arms race" with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
  • Digital
    Guoqiao Li, Ying Li, Zelin Li, Meiyi Zeng.
    ScienceDirect2018
    1. Discovery of Artemisinin and History of Research and Discovery of Artemisinin Antimalarials; 2. Biological Research of Artemisia annua L; 3. Chemical Research on Artemisinin; 4. Artemisinin Derivatives and Analogues; 5. Pharmacological Study on Artemisinin and Its Derivatives; 6. Clinical Studies of Artemisinin and its Derivatives; 7. Artemether and Lumefantrine Combination; 8. Artemisinin and Naphthoquine Phosphate Combination; 9. The Combination of Artemisinin Drugs and Pyronaridine; 10. Artemisinins and piperaquine phosphate combinations
  • Print
    edited by Richard G. Wax, Kim Lewis, Abigail A. Salyers, Harry Taber.
    Status: Not Checked OutLane Catalog Record
    Microbial drug resistance: a historical perspective / William C. Summers -- Ecology of antibiotic resistance genes / Abigail A. Salyers, Nadja Shoemaker, and David Schlesinger -- Global response systems that confer resistance / Paul F. Miller and Philip N. Rather -- Multidrug efflux pumps: structure, mechanism, and inhibition / Olga Lomovskaya ... [et al.] -- Mechanisms of aminoglycoside antibiotic resistance / Gerard D. Wright -- Resistance to [beta]-lactam antibiotics mediated by [beta]-lactamases : structure, mechanism, and evolution / Jooyoung Cha, Lakshmi P. Kotra, and Shahriar Mobashery -- Target modification as a mechanism of antimicrobial resistance / David C. Hooper -- Antibiotic permeability / Harry Taber -- Genetic methods for detecting bacterial resistance genes / Ad C. Fluit -- Evolution and epidemiology of antibiotic-resistant pneumococci / Christopher Gerard Dowson and Krzysztof Trzcinski -- Antimicrobial resistance in the enterococcus / George M. Eliopoulos -- Methicillin resistance in staphylococcus aureus / Keeta S. Gilmore, Michael S. Gilmore, and Daniel F. Sahm -- Mechanism of drug resistance in mycobacterium tuberculosis / Alex S. Pym and Stewart T. Cole -- Antibiotic resistance in enterobacteria / Nafsika H. Georgopapadakou -- Resistance as a worldwide problem / Paul Shears -- Public health responses to antimicrobial resistance in outpatient and inpatient settings / Cindy R. Friedman and Arjun Srinivasan -- Antibacterial drug discovery in the 21st century / Steven J. Projan.
  • Digital
    edited by Cheng Liu, K. John Morrow Jr.
    Wiley2017
    The history of therapeutic monoclonal antibodies / Regis Sodoyer -- Structure, classification and naming of therapeutic monoclonal antibodies / Zhinan Xia -- Mechanism of action for therapeutic antibodies / Yu Zhou and James D. Marks -- Therapeutic monoclonal antibodies and their targets / Maurizio Chiriva-Internati, et al -- Antibody post-translational modifications / Roy Jefferis -- The pharmacology, pharmacokinetics, and pharmacodynamics of antibodies / Ningning Xu, Meimei Liu, Margaret Liu -- Monoclonal antibodies : applications in clinical oncology / Jeanene ("Gigi") Robison -- Development of biosimilar rituximab and clinical experience / Reena Nair -- Monoclonal antibodies for infectious diseases / Steven J. Projan -- Monoclonal antibodies for musculoskeletal, CNS, and other diseases / Junming Yie and Tao Wu -- Manufacture of recombinant therapeutic proteins using chinese hamster ovary cells in large-scale bioreactors : history, methods and perspectives / Florian M. Wurm and Maria De Jesus -- Process development / Samuel D. Stimple and David W. Wood -- Biosimilars and biobetters : impact on biopharmaceutical manufacturing and CMOs / Ronald A. Rader -- Cell line and cell culture development for biosimilar antibody drug manufacturing / Jianguo Yang -- Product analysis of biosimilar antibodies / Weidong Jiang, Scott Liu and Ziyang Zhong -- Bioanalytical development / Rafiq Islam -- Preclinical and clinical development of biosimilar antibodies / João Eurico Fonseca and João Gonçalves -- Regulatory issues / Clarinda Islam -- Legal considerations / K. Lance Anderson, Jennifer R. Moore Meline, and Jonathan D. Ball -- ADCC enhancement technologies for next generation therapeutic antibodies / Cheng Liu and Su Yan -- Biosimilar antibody half-life : engineering for optimal performance / K. John Morrow, Jr -- Technologies for antibody drug conjugation / Patrick G. Holder and David Rabuka.
  • Digital
    edited by Jian Wang, James D MacNeil, Jack Frank Kay.
    Wiley2012
    Antibiotics : groups and properties / Philip T. Reeves -- Pharmacokinetics, distribution, bioavailability, and relationship to antibiotic residues / Peter Lees and Pierre-Louis Toutain -- Antibiotic residues in food, drinking water, and food safety regulations / Kevin J. Greenlees, Lynn G. Friedlander, and Alistair Boxall -- Sample preparation : extraction and clean-up / Alida A.M. (Linda) Stolker and Martin Danaher -- Bioanalytical screening methods / Sara Stead and Jacques Stark -- Chemical analysis : quantitative and confirmatory methods / Jian Wang and Sherri B. Turnipseed -- Single residue quantitative and confirmatory methods / Jonathan Tarbin [and others] -- Method development and method validation / Jack F. Kay and James D. MacNeil -- Measurement uncertainty / Jian Wang [and others] -- Quality assurance and quality control / Andrew Cannavan, Jack Kay, and Bruno Le Bizec.
  • Digital
    edited by Pedro Merino.
    Wiley2013
    Deoxynucleoside analogues / Vicente Gotor -- Nucleosides modified at the base moiety / Luigi Agrofoglio -- Acyclic nucleosides / Antonin Holy -- Phosphorylated nucleoside analogues / Giovanni Romeo -- Triphosphorylated nucleoside analogues / Chris Meier -- Pro-nucleotides / Christian Perigaud -- C-nucleoside / Sergio Castillón -- Isonucleosides / Vasu Nair -- Conformationally constrained nucleosides / Jacques Lebreton -- Spironucleosides / Maria Jose Camarasa -- L-nucleosides / Daniela Perrone -- Carbocyclic nucleosides / Eric Leclerc -- Uncommon three-, four, and six-membered nucleosides / Elisabetta Groaz -- Thionucleosides / L.S. Jeong -- Azanucleosides and related compounds / Tomas Tejero -- Oxathiolane and dioxolane nucleosides / Annalisa Guaragna -- Isoxazolidinyl nucleosides / Ugo Chiacchio -- Nucleoside antibiotics / Apurba Dutta -- Building blocks for peptide nucleic acids / Pedro Merino.
  • Digital
    Robert W. Finberg, Roy Guharoy.
    Springer2012
  • Digital
    Uwe Frank, Evelina Tacconelli.
    Springer2009
  • Digital
    Uwe Frank, Evelina Tacconelli.
    Springer2012
    Classification of the Antibiotics -- Antibiotics Marketed in the EU -- Principles of Antibiotic Therapy -- The Most Common Errors in Antibiotic Therapy -- Important Infections and Their Microbiological Diagnosis -- Cooperation with Microbiologists -- Resistance of Major Clinical Pathogens -- The Most Frequent Pathogens- Choice of Antibiotics -- Antibiotics, Antimycotics: Spectrum- Dosage- Adverse Effects- Costs -- Antibiotic Therapy of the Principal Infections in Children and Adults -- Treatment of the Most Frequent Types of Bacterial Endocarditis -- Minimal Duration of Treatment for Bacterial Infections -- Failure of Antibiotic Therapy -- Fever of Unknown Origin: Differential Diagnosis -- Dosage of Antibiotics in Impaired Renal Function -- Antibiotic Therapy in Haemodialysis, Peritoneal Dialysis, and Continuous Haemofiltration -- Antibiotic Therapy During Pregnancy and Lactation -- Antibiotics in Liver Diseases -- Diffusion of Antibiotics in Cerebrospinal Fluid and in Cerebral Abscesses -- Local Antibiotics -- Prophylactic Antibiotic Therapy -- Physical Incompatibility of Antibiotics and Antimycotics in Infusion Solutions -- Useful Websites.
  • Digital
    Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors.
    Springer2012
    1. Translational Strategies for Development of Antibody-Based Therapeutics: An Overview / Mohammad Tabrizi, Gadi Gazit Bornstein and Scott L. Klakamp -- 2. Discovery Process for Antibody-Based Therapeutics / Heather H. Shih -- 3. Technologies for the Generation of Human Antibodies / Ramesh R. Bhatt, John S. Haurum and C. Geoffrey Davis -- 4. Application of Antibody Engineering in the Development of Next Generation Antibody-Based Therapeutics / Randall J. Brezski and Juan Carlos Almagro -- 5. Biophysical Considerations for Development of Antibody-Based Therapeutics / Andrew W. Drake and Giuseppe A. Papalia -- 6. Considerations in Establishing Affinity Design Goals for Development of Antibody-Based Therapeutics / Mohammad Tabrizi -- 7. Bioanalytical Considerations for Development of Antibody-Based Therapeutics: Pharmacokinetics and Immunogenicity / Cherryl B. Funelas and Scott L. Klakamp -- 8. Preclinical Considerations for Development of Antibody-Based Therapeutics in Oncology / Gregory Landes and Kathleen Elias -- 9. Factors Impacting the Tumor Localization and Distribution of Antibody-Based Therapeutics in Oncology / David C. Blakey -- 10. Preclinical Safety Considerations for the Development of Antibody-Based Therapeutics / Lolke de Haan -- 11. Application of Pharmacokinetic/Pharmacodynamic Modeling in the Development of Antibody-Based Therapeutics / Donald E. Mager -- 12. Application of Population Pharmacokinetic-Pharmacodynamic Approaches in the Design of Translational Strategies for Development of Antibody-Based Therapeutics / Feng Jin -- 13. Translational Biomarkers: Essential Tools in Development of Antibody-Based Therapeutics / Mohammad A. Tabrizi and Cherryl B. Funelas -- 14. Translational Research in Alzheimer's Disease for Development of Antibody-Based Therapeutics / Eric C. Yuen, Enchi Liu and Gene G. Kinney -- 15. Considerations in Manufacturing Process Development for Antibody-Based Therapeutics / Paula C. Miller and Peiling Xu -- 16. Strategies for Development of Next Generation Antibody-Based Therapeutics / Mohammad Tabrizi and Gadi Gazit Bornstein -- 17. Immune Complex Therapies for Treatment of Immune Thrombocytopenia / Rong Deng and Joseph P. Balthasar -- 18. Application of Bioinformatics Principles for Target Evaluation / Anthony Carvalloza, Mohammad Fallahi and Sahba Tabrizifard -- 19. Concluding Remarks / Mohammad Tabrizi, Gadi Gazit Bornstein and Scott L. Klakamp.
  • Digital
    Syed Tabish R. Zaidi and Jason A. Roberts, edtiors.
    Springer2016
    Betalactams: Penicillins -- Betalactams: Cephalosporins -- Aminoglycosides -- Quinolones -- Carbapenems -- Glycopeptides and antibiotics for Gram-Positive Bacterial Infections -- Azole antifungals -- Echinocandins antifungals -- Polyene antifungals -- Miscellaneous antimicrobials. .
  • Digital
    Stephen C. Piscitelli, Keith A. Rodvold, Manjunath P. Pai, editors.
    Springer2011
    Introduction to Drug-Drug Interactions -- Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion -- Mechanisms of Drug Interactions II: Transport Proteins -- Drug-Food Interactions -- Interactions Between Herbs and Antiinfective Medications -- Drug-Cytokine Interactions -- Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions with Antiretrovirals for HIV Infection -- Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelmintic Agents -- Drug Interaction Considerations Throughout Drug Development -- Probe Cocktail Studies -- Design and Data Analysis in Drug Interaction Studies.
  • Digital
    editors, Masao Omata, Tatsuo Kanda.
    Future Med2013
    Hepatitis C virus infection : from discovery to eradication / Masao Omata & Tatsuo Kanda -- Interferons in clinical trials / Tatsuo Kanda, Osamu Yokosuka & Masao Omata -- Protease inhibitors / Marion Corouge, Philippe Sogni & Stanislas Pol -- NS5A inhibitor : daclatasvir / Kazuaki Chayama & C. Nelson Hayes -- Toll-like receptor agonists for nonresponders to HCV treatment : hope versus promise? / Valérie Martel-Laferrière & Douglas Dieterich -- Treatment options in HIV-HCV-coinfected patients / Philippe Sogni, Marion Corouge & Stanislas Pol -- Treatment options for dual HCV/HBV coinfection / Chun-Jen Liu & Jia-Horng Kao -- HCV treatment in patients with metabolic syndrome / Luigi E. Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo & Paola Loria -- Future directions in hepatitis C therapy / Stevan A. Gonzalez -- Index.
  • Digital/Print
    Digital : WHO2012
    Print2012
    Chapter 1. The evolving threat of antimicrobial resistance: Introduction -- Chapter 2. Surveillance to track antimicrobial use and resistance in bacteria -- Chapter 3. Measures to ensure better use of antibiotics -- Chapter 4. Reducing antimicrobial use in animal husbandry -- Chapter 5. Infection prevention and control in health-care facilities -- Chapter 6. Fostering innovation to combat antimicrobial resistance -- Chapter 7. The way forward: political commitment to enable options for action -- Appendix 1. List of 2001 WHO Global Strategy for Containment of Antimicrobial Resistance recommendations -- Appendix 2. List of 2011 WHO World Health Day six-point policy briefs.
  • Digital
    edited by Alexander Vinks, Hartmut Derendorf, Johan Mouton.
    Springer2014
    Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in making predictions under new or changing pre-clinical and clinical circumstances. Not surprisingly, pharmacokinetic-pharmacodynamic modeling concepts are increasingly applied in both basic and clinical research as well as in drug development. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics is designed as a reference on the application of pharmacokinetic-pharmacodynamic principles for the optimization of antimicrobial therapy, namely pharmacotherapy, and infectious diseases. The reader is introduced to various aspects of the fundamentals of antimicrobial pharmacodynamics, the integration of pharmacokinetics with pharmacodynamics for all major classes of antibiotics, from basic research to clinical situations.
  • Digital
    Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, editors.
    Springer2015
    This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle.
  • Digital
    [edited by] Julia A. McMillan MD, Carlton K.K. Lee, PharmD, MPH, George K. Siberry, MD, MPH, Karen C. Carroll, MD.
    ClinicalKey2014
    Infectious agents and drugs of choice / Julia A. McMillan, Julia A. McMillan and George K. Siberry -- Recommended empiric antimicrobial therapy for selected clinical syndromes / Hiwot Hiruy, Swathi Gowtham, and Paul Sue -- Drug dosing in special circumstances / Angela Helder, Elizabeth A. Sinclair, and Carlton K.K. Lee -- Mechanisms of action and routes of administration of antimicrobial agents / Karen C. Carroll -- Mechanisms of drug resistance / Karen C. Carroll -- Therapeutic drug monitoring / Kristine A. Parbuoni and Carlton K.K. Lee -- Adverse drug reactions / Melissa D. Makii and Carlton K.K. Lee -- Recommended antimicrobial prophylaxis for selected infectious agents and conditions / Julia A. McMillan and George K. Siberry -- Antimicrobial desensitization protocols / Lisa A. Degnan and Carlton K.K. Lee -- Formulary / Carlton K.K. Lee.
  • Digital
    edited by Gottfried Unden, Eckhard Thines, and Anja Schüffler.
    Wiley2016
    Adaptation of Microbial Metabolism in Host/Pathogen Interaction. Metabolic Adaptation of Human Pathogenic / Ann Kathrin Heroven, Petra Dersch -- Crosstalk between Metabolism and Virulence of / Klaus Heuner, Wolfgang Eisenreich -- Metabolism of Intracellular / Peter Holtkötter, Michael Hensel -- The Human Microbiome in Health and Disease / Cian Hill, R Paul Ross, Catherine Stanton, Paul W O'Toole -- Mechanisms of Dysbiosis in the Inflamed Gut / Sebastian E Winter -- Strategies for Nutrient Acquisition by during the Infection of Rice / Andrew J Foster, George R Littlejohn, Darren M Soanes, Nicholas J Talbot -- New Inhibitors and Targets of Infectious Diseases. Outer Membrane Proteins as Potential Anti-infective Drug Targets in / Robert L Davies -- Identification of Anti-infective Compounds Using Amoebae / Christopher F Harrison, Hubert Hilbi -- Stress Biology in Fungi and "Omic" Approaches as Suitable Tools for Analyzing Plant-Microbe Interactions / Stefan Jacob, Alexander Yemelin -- Targeting Plasmids: New Ways to Plasmid Curing / Anja Schüffler, Corinna Kübler -- Regulation of Secondary Metabolism in the Gray Mold Fungus / Muriel Viaud, Julia Schumacher, Antoine Porquier, Adeline Simon.
  • Digital
    Marc Stadler, Petra Dersch, editors.
    Springer2016
    Tackling threats and future problems of multidrug-resistant bacteria.-Emergence and spread of antimicrobial resistance: recent insights from bacterial population genomics -- Epidemiology of Staphylococcus aureus nasal carriage patterns in the community -- Diagnostics and resistance profiling of bacterial pathogens -- Use of antibiotics and antimicrobial resistance in veterinary medicine as exemplified by the swine pathogen Streptococcus suis.-Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem and the susceptibility to infections -- Anti-virulence strategies to target bacterial infections -- Strategies to block bacterial pathogenesis by interference with motility and chemotaxis -- New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy -- History of antibiotics research -- Actinobacteria and Myxobacteria -- Two of the most important bacterial resources for novel antibiotics -- Exploitation of fungal biodiversity for discovery of novel antibiotics -- Strategies for the discovery and development of new antibiotics from natural products: Three Case Studies -- New structural templates for clinically validated and novel targets in antimicrobial drug research and development -- Synthesis of antibiotics -- Antibiotics clinical development and pipeline -- Anti-infectives in drug delivery -- overcoming the Gram-negative bacterial cell envelope.
  • Digital
    Arch G. Mainous III, Claire Pomeroy, editors.
    Springer2010
  • Digital
    editor, Vladimir Krcméry.
    Future Med2013
    Antibiotic resistance : postantibiotic era is here / Vladimir Krcmery -- Current challenges in treating methicillin-resistant Staphylococcus aureus : what are the options? / Noha E.I. Sakka & Ian M . Gould -- Antimicrobial-resistant Streptococcus pneumoniae : trends and management / Michael R. Jacobs -- Emergence and management of drug-resistant enterococcal infections / William R. Miller, Barbara E. Murray & Cesar A. Arias -- Enterobacteriaceae that produce newer b-lactamases / Johann D.D. Pitout -- Extensively drug-resistant tuberculosis : new strains, new challenges / Megan Coffee -- Clinical significance of extended-spectrum b-lactamases / Jesés Rodréguez-Baño, Belén Gutiérrez, Lorena Lépez-Cerero & Alvaro Pascual -- Plasmid-mediated quinolone resistance / José Manuel Rodréguez-Marténez, Maréa Eliecer Cano, Jorge Calvo, Álvaro Pascual & Luis Marténez-Marténez -- Antibiotic resistance in the absence of antimicrobial use / Lucia Pallecchi, Alessandro Bartoloni, Eduardo Gotuzzo & Gian Maria Rossolini -- Resistance in bacteria of the food chain : epidemiology and control strategies / Lina Maria Cavaco & Frank Møller Aarestrup -- Measures to prevent antimicrobial resistance / Vhairi M. Bateman & Ian M. Gould -- Where does novel antibiotics R&D stand among other pharmaceutical products? / Glenn S. Tillotson -- Resistance to antiretroviral drugs / Manuela Colafigli, Simona Di Giambenedetto & Roberto Cauda -- Index.
  • Digital
    Jeremy Nuttall, editor.
    Springer2014
    One of the most promising new approaches for the prevention of HIV transmission, particularly for developing countries, involves topical, self-administered products known as microbicides. The development of microbicides is a long and complicated process, and this volume provides an overview of all the critical areas, from the selection of appropriate candidate molecules and their formulation, preclinical and clinical testing for safety and efficacy, strategies for product registration and finally, issues associated with product launch, distribution and access. The book will prove valuable to both those working in the field and all others who are interested in learning more about this product class, which has the potential to significantly impact the future of this devastating epidemic.
  • Digital
    editor, Jan B. Vermorken.
    Future Med2013
    Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Jan B. Vermorken -- Colorectal cancer / Christian Rolfo, Giuseppe Bronte, Antonio Russo & Marc Peeters -- Breast cancer / Sevilay Altintas -- Lung cancer and genitourinary cancers / Dirk Schrijvers -- Tumors of the skin, the CNS and the head and neck / Pol Specenier -- Gynecologic cancers / Jan B. Vermorken -- Index.
  • Digital
    [edited by] Walter A. Hall, Peter D. Kim.
    Thieme MedOne Neurosurgery2014
    Immunology of the CNS / Pragati Nigam and Maciej Lesniak -- Microbiological diagnosis of CNS / Yuriko Fukuta and Karin E. Byers -- Antibiotics and development of resistance / Peter D. Kim and Walter A. Hall -- Radiology of infections of the CNS / Kunal M. Patel and Charles L. Truwit -- Viral infections of the CNS -- Joseph B. Domachowske and Manika Suryadevara -- Fungal infections of the CNS / Walter A. Hall and Peter D. Kim -- Parasitic infections of the CNS / Ali Akhaddar and Mohamed Boucetta -- Bacterial brain abscess / Peter D. Kim and Walter A. Hall -- Meningeal infections / Manika Suryadevara and Joseph B. Domachowske -- Epidural and subdural infections / Sandi K. Lam and Peter C. Warnke -- Intracranial vascular infections / Hoon Choi, Walter A. Hall, and Eric M. Deshaies -- Vertebral column infections / Kyle I. Swanson and Daniel K. Resnick -- Spinal canal infections / Ian E. McCutcheon -- Neurosurgical antibiotic prophylaxis / DaraspreetKainth, Dino Terzic, and Stephen J. Haines -- Postoperative intracranial infections / Arya Nabavi, Friederike Knerlich-Lukoschus, and Andreas M. Stark -- Implanted devices and CNS infection / Ramesh Grandhi, Gillian Harrison, and Elizabeth C. Tyler-Kabara -- Pediatric CNS infections / Ian Mutchnick and Thomas Moriarty -- Immune compromise and CNS infections / Ouzi Nissim ... [et al.] -- Systemic infections in neurocritical care / Michael F. Regner ... [et al.].
  • Digital
    edited by W. Scott Champney.
    Springer Protocols2008
  • Digital
    edited by David A. Phoenix, Frederick Harris and Sarah R. Dennison.
    Wiley2015
    The problem of microbial drug resistance -- Conventional antibiotics -- revitalized by new agents -- Developing novel bacterial targets: carbonic anhydrases as antibacterial drug targets -- Magainins -- a model for development of eukaryotic antimicrobial peptides (amps) -- Antimicrobial peptides from prokaryotes -- Peptidomimetics as antimicrobial agents -- Synthetic biology and therapies for infectious diseases -- Nano-antimicrobials based on metals -- Natural products as antimicrobial agents -- an update -- Photodynamic antimicrobial chemotherapy -- The antimicrobial effects of ultrasound -- Antimicrobial therapy based on antisense agents -- New delivery systems -- liposomes for pulmonary delivery of antibacterial drugs.
  • Digital
    volume editors, Denis F. Kinane, Andrea Mombelli.
    Karger2012
    Subgingival biofilm structure / V. Zijnge, T. Ammann -- Microbial diversity and interactions in subgingival biofilm communities / P.I. Diaz -- Innate cellular responses to the periodontal biofilm / M. Benakanakere, D.F. Kinane -- Neutrophils in periodontal inflammation / D.A. Scott, J.L. Krauss -- Antimicrobial peptides in periodontal innate defense / S.-U. Gorr -- Modern approaches to non-surgical biofilm management / D.A. Apatzidou -- Animal models to study host-bacteria interactions involved in periodontitis / D.T. Graves ... [et al.] -- Antimicrobial advances in treating periodontal diseases / A. Mombelli -- Regenerative periodontal therapy / D.W.K. Kao, J.P. Fiorellini -- Paradigm shift in the pharmacological management of periodontal diseases / H. Hasturk, A. Kantarci, T.E. Van Dyke.
  • Digital
    edited by Uwe Gottschalk.
    Wiley2017
  • Digital/Print
    Digital : Silverchair1970-
    Red Book Online is the online home of the Report of the AAP Committee on Infectious Diseases. Offering instant Web-based access, includes complete text of the Red Book, plus the complete visual library of images from the Visual Red Book on CD-ROM and more.
  • Digital/Print
    Digital : Silverchair1970-
    Red Book Online is the online home of the Report of the AAP Committee on Infectious Diseases. Offering instant Web-based access, includes complete text of the Red Book, plus the complete visual library of images from the Visual Red Book on CD-ROM and more.
  • Digital
    [edited by] Huiliang Cao.
    TandFonline2017
    Bioinspired synthesis of silver nanoparticles : characterization, mechanism, and applications -- Tuning the properties of silver monolayer for biological applications -- Synergistic antimicrobial activity of silver and chitosan -- Titania nanotubes as silver nanoparticle carriers to prevent implant-associated infection -- Polymer-silver nanocomposites : preparation, characterization, and antibacterial mechanism -- Dissolution of silver nanoparticles -- Silver as an antimicrobial agent : the resistance issue -- The risks of silver nanoparticles to human body -- Imunomodulatory activities of silver nanoparticles (Ag NPs) in human neutrophils -- Evaluating the interactions of silver nanoparticles and mammalian cells based on biomices technologies -- Methods and tools for assessing nanomaterials and uses and regulation of nanosilver in Europe -- Toward selectively toxic silver nanoparticles -- Orthopaedic implant-associated infections : pathogenesis, clinical presentation and management -- Dental implant infection : typical causes and control -- Guidelines for nanosilver-based antibacterial devices.

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page
TO INSTALL, RIGHT CLICK this button.

What is it?

Derived from Current Medical Diagnosis & Treatment, AccessMedicine's Quick Medical Diagnosis & Treatment provides topic reviews with key diagnostic and treatment features for more than 500 diseases.

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used to answer questions quickly at the point-of-care. Easy-to-interpret Levels of Evidence help clinicians rapidly determine the quality of the available evidence.

Biomedical and pharmacological abstracting and indexing database of published literature, by Elsevier. Embase® contains over 32 million records from over 8,500 currently published journals (1947-present) and is noteworthy for its extensive coverage of the international pharmaceutical and alternative/complementary medicine literature.

Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialties.Provides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.